Podcast Episode Details
Back to Podcast Episodes
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Season 25 Episode 134
Dr Laura Huppert from the University of California, San Francisco, discusses approved and investigational antibody-drug conjugates in the current and future management of HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
Published on 3 weeks, 4 days ago